M&A Deal Summary |
|
|---|---|
| Date | 2024-11-21 |
| Target | Extract Labs |
| Sector | Consumer Products |
| Buyer(s) | CV Sciences |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2010 |
| Sector | Life Science |
| Employees | 47 |
| Revenue | 16M USD (2024) |
CV Sciences is a drug development company focused on products containing the hemp plant extract cannabidiol (CBD) as the active pharmaceutical ingredient. CV Sciences was founded in 2010 and is headquartered in San Diego, California.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 4 |
| Sector: Consumer Products M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 4 of 4 |
| State: Colorado M&A | 2 of 2 |
| Country: United States M&A | 3 of 3 |
| Year: 2024 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-05-13 |
Elevated Softgels
Grand Junction, Colorado, United States Elevated Softgels is a manufacturer of encapsulated soft gels and tinctures for the supplement and nutrition industry. The company's operational flexibility allows low to large minimum order quantity ("MOQ") production runs, allowing for efficient use of capital and increasing speed to market for new product development. Elevated Softgels is based in Grand Junction, Colorado. |
Buy | - |
